Newsfeeds - Spark Newswire

2 minute read

Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey’s District Court

Today, 8:49 AM

Jazz Pharmaceuticals (NASDAQ: JAZZ), a drug company behind the CBD-based medication Epidiolex, recently filed a lawsuit against Teva Pharmaceutical Industries Ltd (NYS

GWPH

2 minute read

Study Suggests Whole-Plant Medicinal Cannabis Could Be More Effective Than CBD In Epilepsy Treatment

By Nicolas Jose Rodriguez

Today, 8:49 AM

Epileptic seizure frequency fell by an average of 86% among ten children treated with whole-plant medicinal cannabis, reveals a case series published in the open-access journal BMJ Paediatrics Open.

GWPH

3 minute read

Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance

By Nicolas Jose Rodriguez

Today, 8:49 AM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon for the third quarter of 2021 and updated financial guidance for 2021.

GWPH

2 minute read

Jazz Pharmaceuticals Q2 Revenue Jumps 34% To $751.8M With $109.5M Epidiolex Net Sales, Reaffirms Its 2021 Guidance Of $3.02B

By Nina Zdinjak

Today, 8:49 AM

Biopharmaceutical company Jazz Pharmaceuticals plc (NASDAQ: JAZZ) reported its financial results on Tuesday for the second quarter of 2021 with total revenue of $751.81 million, up by 34% from $562.43 million in the

GWPH

3 minute read

Does Big Business Provide A Better Look Into Cannabis Reform Than Capitol Hill? Operators Believe So.

By Andrew Ward

Today, 8:49 AM

Cannabis operators and executives tell Benzinga that the movement of private and public companies may serve as a better indicator of regulatory activity than the federal government. At the very least, they say that the industry has made advancements so far without the efforts of Capitol Hill.

COST

11 minute read

The Week In Cannabis: Justice Clarence Thomas, Mexico’s Decriminalization, Apple’s Policy Changes, Tilray And More

By Javier Hasse

Today, 8:49 AM

Below is a recap of the main news related to the cannabis industry and markets for the week of June 28, 2021.

AAPL

2 minute read

Global Cannabis Stocks Decline 8.7% in Q2, Agrify, KushCo Among Strongest Cannabis Names In June

By Jelena Martinovic

Today, 8:49 AM

The Global Cannabis Stock Index fell for the fourth straight month, dropping 4.1% to 57.10. During the second quarter, the index was down 8.7%. After gaining 5.2% in 2020 when it ended at 44.39, the index is up 28.6% in 2021 and has gained 94.2% over the past year. The index dropped 38.3% from its 2021 closing high of 92.48 on February 10.

AGFY

16 minute read

A Complete List Of NYSE And NASDAQ-Listed Cannabis Companies (Updated)

By Benzinga Cannabis

Today, 8:49 AM

As the cannabis industry keeps pushing forward, more companies are moving to list their stock on a major U.S. exchange like the NYSE or NASDAQ. The club, however, remains relatively small.

ABBV

2 minute read

Uncategorized

Jazz Pharmaceuticals Closes On Acquisition Of GW Pharma, Adds CBD Drug Epidiolex To Portfolio

By Jelena Martinovic

Today, 8:49 AM

The biopharmaceutical company Jazz Pharmaceuticals (NASDAQ: JAZZ), has finalized the acquisition of the cannabinoid drug company GW Pharmaceuticals plc. (NASDAQ: GWPH).

GWPH